Both X-ray repair cross-complementing group 1 (XRCC1) and 8-oxoguanine DNA glycosylase 1 (OGG1) are components of the BER pathway, and polymorphisms in XRCC1 and OGG1 are clinically important in various human cancers [60,61]. The gene discussed is XRCC1; the disease is cancer.